Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.
AdaptHealth Corp (AHCO) delivers essential home medical equipment and healthcare-at-home services, empowering patients through respiratory care, mobility solutions, and chronic condition management. This page provides centralized access to all official company announcements and market-relevant developments.
Investors and healthcare professionals will find timely updates on earnings reports, regulatory milestones, product launches, and strategic partnerships. Our curated collection includes press releases on sleep therapy innovations, respiratory equipment advancements, and operational expansions across AHCO's nationwide network.
Key areas covered include quarterly financial results, clinical service enhancements, Medicare/Medicaid compliance updates, and technology integrations in home healthcare. All content is sourced directly from AdaptHealth's communications to ensure accuracy and relevance for stakeholders.
Bookmark this page for streamlined access to AHCO's latest business developments. Check regularly for updates impacting the home healthcare sector and AdaptHealth's position within this critical industry.
AdaptHealth Corp. (NASDAQ: AHCO), a leader in healthcare-at-home solutions, announced its participation in a fireside chat at the BofA Securities Home Care Conference on Monday, December 6, at 3:40 pm ET. Key executives, including Steve Griggs (CEO), Josh Parnes (President), and Jason Clemens (CFO), will represent the company. AdaptHealth serves around 3.5 million patients annually and offers a wide range of medical products and services across all 50 states, partnering with various healthcare providers to improve patient care.
AdaptHealth Corp. (NASDAQ: AHCO), a leader in healthcare-at-home solutions, announced that CFO Jason Clemens will participate in a fireside chat at the BofA Securities Leveraged Finance Conference on Thursday, December 2 at 9:00 am ET. The company provides a range of services including home medical equipment and supplies, focusing on patient-centered care. With a network of over 700 locations, AdaptHealth serves approximately 3.5 million patients across all 50 states, offering solutions for chronic conditions and various medical needs.
AdaptHealth Corp. (NASDAQ: AHCO) announced that CEO Steve Griggs, President Josh Parnes, and CFO Jason Clemens will participate in a fireside chat at the Jefferies London Healthcare Conference. The presentation will be available on-demand starting Thursday, November 18, before market open, accessible via the Investors section of AdaptHealth’s website (www.adapthealth.com). AdaptHealth is a leader in providing healthcare-at-home solutions, reaching approximately 3.5 million patients annually across the U.S.
AdaptHealth Corp. (NASDAQ: AHCO) announced that its CEO Steve Griggs, President Josh Parnes, and CFO Jason Clemens will participate in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on November 17 at 1:20 pm ET. A live webcast will be available through the Investors section of AdaptHealth’s website. The company is a leader in providing patient-centered, healthcare-at-home solutions, serving approximately 3.5 million patients annually across 716 locations in 47 states with a full suite of medical products.
AdaptHealth Corp. (NASDAQ: AHCO) reported a record net revenue of $653.3 million for Q3 2021, a 130% increase from the previous year, alongside a net income of $58.1 million, reversing a $51 million loss. Adjusted EBITDA surged 194% to $156.3 million. The company completed six acquisitions and has increased its fiscal 2021 revenue guidance to $2.41-$2.46 billion. For 2022, guidance is set at $2.70-$2.90 billion in revenue. Management is confident in driving organic growth through strategic acquisitions despite market challenges.
AdaptHealth Corp. (NASDAQ: AHCO) is set to release its third quarter 2021 financial results before the market opens on
AdaptHealth Corp. (NASDAQ: AHCO) has announced the appointment of Greg Belinfanti to its Board of Directors, representing One Equity Partners. Belinfanti brings extensive board experience, having served on various healthcare-related boards, including Arthrocare (NASDAQ: ARTC). Brad Coppens, the previous OEP designee, will remain an independent director. Chairman Richard Barasch expressed appreciation for OEP's support and welcomed Belinfanti's expertise, which aims to strengthen the board's leadership and strategic direction.
AdaptHealth Corp. (NASDAQ: AHCO) has announced a successful pricing of $600 million in 5.125% senior notes due 2030, increasing from a previously planned $550 million. The offering is aimed at qualified institutional buyers and is expected to close on August 19, 2021. Proceeds will be used to repay existing promissory notes, pay off revolving credit, cover related fees, and for general corporate needs, including acquisitions. The notes will be guaranteed by certain subsidiaries and the Issuer’s parent company.
AdaptHealth Corp. (NASDAQ: AHCO) announced the commencement of a $550 million offering of senior notes due 2030 through its subsidiary, AdaptHealth LLC. These senior notes will be guaranteed by certain subsidiaries and the parent company on a senior unsecured basis. The net proceeds will be used to repay outstanding debt, including 12% promissory notes and amounts under its revolving credit facility, as well as for general corporate purposes. The offering is targeted at qualified institutional buyers and is not registered under the Securities Act.
AdaptHealth Corp. (NASDAQ: AHCO) has appointed Anton Hie as the new Vice President of Investor Relations. This newly created position will see Mr. Hie working closely with senior management to enhance the company's growth and competitive strategy, managing communications with shareholders and the investment community. With 20 years of experience in healthcare investment, including 12 years at RBC Capital Markets, Hie brings substantial expertise to the team. AdaptHealth serves approximately 3.3 million patients annually across 678 locations in 47 states.